Evidence map›Paper›PMID 39136687›Full record

ArticleeLife2024

SPARK regulates AGC kinases central to the

Alice L Herneisen, Michelle L Peters, Tyler A Smith, Emily Shortt, Sebastian Lourido

Abstract read
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Alice L HerneisenWhitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.ORCID https://orcid.org/0000-0003-3368-0893
Michelle L PetersWhitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.
Tyler A SmithWhitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.
Emily ShorttWhitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.
Sebastian LouridoWhitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, United States.ORCID https://orcid.org/0000-0002-5237-1095

Funding

Control of parasite invasion by a microneme protein complex conserved in ApicomplexansR01AI144369 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI LOURIDO, SEBASTIAN · 2020 to 2024
$2.4M
National Science Foundation Graduate Research Fellowship Program 174530National Science Foundation Graduate Research Fellowship Program 2018259980NIAID NIH HHS R01 AI144369NIH HHS R01AI144369
6 · The paper itself

Abstract

Apicomplexan parasites balance proliferation, persistence, and spread in their metazoan hosts. AGC kinases, such as PKG, PKA, and the PDK1 ortholog SPARK, integrate environmental signals to toggle parasites between replicative and motile life stages. Recent studies have cataloged pathways downstream of apicomplexan PKG and PKA; however, less is known about the global integration of AGC kinase signaling cascades. Here, conditional genetics coupled to unbiased proteomics demonstrates that SPARK complexes with an elongin-like protein to regulate the stability of PKA and PKG in the model apicomplexan

Indexed as

Protozoan ProteinsToxoplasmaAnimalsCyclic AMP-Dependent Protein KinasesCyclic GMP-Dependent Protein KinasesProtein Serine-Threonine KinasesReproduction, AsexualSignal TransductionCyclic AMP-Dependent Protein KinasesCyclic GMP-Dependent Protein KinasesProtein Serine-Threonine KinasesProtozoan ProteinsAGC kinasesinfectious diseasemicrobiologysignalingToxoplasma gondii

Identifiers

PMID39136687
PMCPMC11321763

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.